Adv Pharm Bull. 2021;11(1): 96-103.
doi: 10.34172/apb.2021.010
  Abstract View: 450
  PDF Download: 243

Research Article

Lysine Decorated Solid Lipid Nanoparticles of Epirubicin for Cancer Targeting and Therapy

Parvaneh Bayat 1 ORCID logo, Parvaneh Pakravan 1* ORCID logo, Mojtaba Salouti 2, Jafar Ezzati Nazhad Dolatabadi 3

1 Department of Chemistry, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
2 Nanobiotechnology Research Center, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
3 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
*Corresponding Author: Parvaneh Pakravan, Tel: +989127410459, Email: pakravanparvaneh@iauz.ac.ir


Purpose: Cancer is an example of the most important growing diseases in human society and scientists are trying to treat it without considerable side effects on patient’s health. Solid lipids are colloidal nanoparticles that were used in drug delivery due to their several advantages.

Methods: In this work, surface modified targeted solid lipid nanoparticles (SLNs) were fabricated by nano-homogenizer using tripalmitin glyceride and stearic acid as lipid constituents. The size of nanoparticles and morphological evaluations were surveyed using particle size analyzer, scanning electron microscopy; Fourier transforms infrared spectroscopy (FT-IR) and differential scanning calorimetry (DSC).

Results: The particle size of 148.5 and appropriate polydispersity index were achieved for lipid nanoparticles with an entrapment efficiency of 86.1%. The FT-IR analysis confirmed the coupling of lysine to the free functional group of SLNs. DSC proved the conjugation of amino acid to the surface of carriers. The in vitro epirubicin (EPI) release test exhibited the further controlled release phenomenon for the lysine conjugated nanoparticles. The cytotoxicity assay showed lower IC50 of lysine conjugated SLNs of EPI on the investigated cell line.

Conclusion: These studies showed that the fabricated targeted carrier has a very remarkable anticancer effect on breast cancer cell lines in comparison with pure drug.

Keywords: Solid lipid nanoparticles, Epirubicin, Targeted drug delivery, Cytotoxicity
First Name
Last Name
Email Address
Security code

Abstract View: 387

Your browser does not support the canvas element.

PDF Download: 243

Your browser does not support the canvas element.

Submitted: 12 Jan 2020
Revision: 29 Mar 2020
Accepted: 19 Apr 2020
ePublished: 07 Nov 2020
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)